Cargando…

Dietary Patterns of Treatment–Resistant Depression Patients

Depression is a common mental disorder that occurs all over the world with treatment resistance commonly seen in clinical practice. Ketamine exhibits an antidepressant that is more often used in the case of treatment-resistant depression (TRD) in MDD and BP. Research emphasizes that a healthy diet a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mechlińska, Agnieszka, Włodarczyk, Adam, Gruchała-Niedoszytko, Marta, Małgorzewicz, Sylwia, Cubała, Wiesław Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503336/ https://www.ncbi.nlm.nih.gov/pubmed/36145142 http://dx.doi.org/10.3390/nu14183766

Ejemplares similares

Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
por: Mechlińska, Agnieszka, et al.
Publicado: (2023)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Dietary Habits in Children with Respiratory Allergies: A Single-Center Polish Pilot Study
por: Wasilewska, Eliza, et al.
Publicado: (2020)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2020)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
por: Włodarczyk, Adam, et al.
Publicado: (2021)

The impact of nutritional status and appetite on the hospital length of stay and postoperative complications in elderly patients with severe aortic stenosis before aortic valve replacement
por: Jagielak, Dariusz, et al.
Publicado: (2016)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Residual insomnia in major depressive disorder: a systematic review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
por: Szałach, Łukasz Piotr, et al.
Publicado: (2022)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2016)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy
por: Niedoszytko, Marek, et al.
Publicado: (2013)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Gut Microbiota in Depression: A Focus on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2021)

Ketogenic diet for anxiety disorders: Dietary regimen for relapse prevention?
por: Włodarczyk, A., et al.
Publicado: (2021)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
por: Wichniak, Adam, et al.
Publicado: (2021)

Heart rate variability and incidence of depression during the first six months following first myocardial infarction
por: Wilkowska, Alina, et al.
Publicado: (2019)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
por: Wilkowska, Alina, et al.
Publicado: (2019)

Impairment of lung diffusion capacity—a new consequence in the long-term childhood leukaemia survivors
por: Wasilewska, Eliza, et al.
Publicado: (2019)

Clozapine As Transformative Treatment In Bipolar Patients
por: Wilkowska, Alina, et al.
Publicado: (2019)

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Dysphoria and Irritability—Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Celiac Dietary Adherence Test and Standardized Dietician Evaluation in Assessment of Adherence to a Gluten-Free Diet in Patients with Celiac Disease
por: Gładyś, Katarzyna, et al.
Publicado: (2020)

Dietary Habits before and during the COVID-19 Epidemic in Selected European Countries
por: Skotnicka, Magdalena, et al.
Publicado: (2021)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten, Katarzyna, et al.
Publicado: (2016)

Severe skin complications in patients treated with antidepressants: a literature review
por: Herstowska, Marta, et al.
Publicado: (2014)

Comment on ‘The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy’
por: Grzegorzewska, Agata M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2iqgrd658ra4jhoo39j037k2f1